NEW YORK – Bio-Rad Laboratories reported Thursday after the close of the market that its second quarter revenues fell 6 percent year over year, primarily due to COVID-19 pandemic-related slowdowns.
For the three months ended June 30, 2020, Bio-Rad reported revenues of $536.9 million compared to $572.6 million a year ago, besting analysts' average estimate of $517.1 million.
On a currency-neutral basis, Q2 revenues decreased about 4 percent, the company said.